{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:20:09Z","timestamp":1780510809707,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Stress"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ynstr.2020.100220","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T22:23:20Z","timestamp":1587162200000},"page":"100220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4489-8305","authenticated-orcid":false,"given":"Byung Kil","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Fonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-1868","authenticated-orcid":false,"given":"Richard L.","family":"Hauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-4855","authenticated-orcid":false,"given":"Graziano","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan T.","family":"Valovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Rasmusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ynstr.2020.100220_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1440-1681.1991.tb01402.x","article-title":"Neuropeptide Y radio-immunoassay: characterization and application","volume":"18","author":"Allen","year":"1991","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ynstr.2020.100220_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0378-4347(00)81115-9","article-title":"Liquid chromatographic determination of urinary catecholamines after one-step alumina extraction","volume":"424","author":"Anderson","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ynstr.2020.100220_bib3","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.psyneuen.2013.04.020","article-title":"Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe","volume":"38","author":"Baker","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ynstr.2020.100220_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000049028","article-title":"Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder","volume":"9","author":"Baker","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.ynstr.2020.100220_bib53","first-page":"75","article-title":"The development of a Clinician-Administered PTSD Scale","volume":"8","author":"Blake","year":"1995","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.ynstr.2020.100220_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4088\/JCP.09m05106blu","article-title":"Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine","volume":"72","author":"Bonne","year":"2011","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ynstr.2020.100220_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-6952-4_6","article-title":"Genome to phenome: a systems biology approach to PTSD using an animal model","volume":"1598","author":"Chakraborty","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ynstr.2020.100220_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","article-title":"The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ynstr.2020.100220_bib8","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"key":"10.1016\/j.ynstr.2020.100220_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/psyp.12681","article-title":"Sweat pore reactivity as a surrogate measure of sympathetic nervous system activity in trauma-exposed individuals with and without posttraumatic stress disorder","volume":"53","author":"Familoni","year":"2016","journal-title":"Psychophysiology"},{"key":"10.1016\/j.ynstr.2020.100220_bib11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/ajp.152.9.1329","article-title":"Initial reliability and validity of the childhood trauma interview: a new multidimensional measure of childhood interpersonal trauma","volume":"152","author":"Fink","year":"1995","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ynstr.2020.100220_bib12","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders","author":"First","year":"2005"},{"key":"10.1016\/j.ynstr.2020.100220_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11606-010-1497-4","article-title":"Medical care needs of returning veterans with PTSD: their other burden","volume":"26","author":"Frayne","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ynstr.2020.100220_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2016.11.048","article-title":"Considering future pharmacotherapy for PTSD","volume":"649","author":"Friedman","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ynstr.2020.100220_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.psychres.2018.12.034","article-title":"The anxiolytic-like effects of ginsenoside Rg2 on an animal model of PTSD","volume":"279","author":"Gao","year":"2018","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.ynstr.2020.100220_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.biopsych.2010.07.033","article-title":"Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression","volume":"68","author":"Gill","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.ynstr.2020.100220_bib18","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1523\/JNEUROSCI.2305-08.2008","article-title":"The role of neuropeptide Y in the expression and extinction of fear-potentiated startle","volume":"28","author":"Gutman","year":"2008","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ynstr.2020.100220_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.regpep.2012.02.005","article-title":"Plasma neuropeptide Y levels relate cigarette smoking and smoking cessation to body weight regulation","volume":"176","author":"Hussain","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ynstr.2020.100220_bib20","first-page":"E479","article-title":"Nonsaturable entry of neuropeptide Y into brain","volume":"276","author":"Kastin","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ynstr.2020.100220_bib21","first-page":"210","article-title":"Development and preliminary validation of a brief broad-spectrum measure of trauma exposure","volume":"vol. 12","author":"Kubany","year":"2000"},{"key":"10.1016\/j.ynstr.2020.100220_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbi.2014.06.003","article-title":"Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress","volume":"42","author":"Lindqvist","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ynstr.2020.100220_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00365513.2010.493406","article-title":"Biomarkers for rheumatoid arthritis: making it personal","volume":"242","author":"Lindstrom","year":"2010","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.ynstr.2020.100220_bib55","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopsych.2019.02.006","article-title":"Stimulation of Peroxisome Proliferator-Activated Receptor-alpha by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior","volume":"85","author":"Locci","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnbeh.2011.00054","article-title":"Differential regulation of neuropeptide Y in the amygdala and prefrontal cortex during recovery from chronic variable stress","volume":"5","author":"McGuire","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ynstr.2020.100220_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213839","article-title":"Metabolomic analysis of male combat veterans with post traumatic stress disorder","volume":"14","author":"Mellon","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.ynstr.2020.100220_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biopsych.2018.02.007","article-title":"Metabolism, metabolomics, and inflammation in posttraumatic stress disorder","volume":"83","author":"Mellon","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ynstr.2020.100220_bib29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0006-3223(03)00433-5","article-title":"Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels","volume":"54","author":"Morgan","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib30","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression","volume":"2","author":"Passos","year":"2015","journal-title":"Lancet. Psy."},{"key":"10.1016\/j.ynstr.2020.100220_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.psyneuen.2018.04.024","article-title":"PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma","volume":"93","author":"Pineles","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ynstr.2020.100220_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnbeh.2019.00114","article-title":"Animal models of PTSD: the socially isolated mouse and the biomarker role of allopregnanolone","volume":"13","author":"Pinna","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ynstr.2020.100220_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fncel.2014.00256","article-title":"Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder","volume":"8","author":"Pinna","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ynstr.2020.100220_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0028-3908(99)00149-5","article-title":"Brain allopregnanolone regulates the potency of the GABA(A) receptor agonist muscimol","volume":"39","author":"Pinna","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ynstr.2020.100220_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrn3339","article-title":"Biological studies of post-traumatic stress disorder","volume":"13","author":"Pitman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ynstr.2020.100220_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neubiorev.2019.03.015","article-title":"Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans","volume":"105","author":"Raber","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ynstr.2020.100220_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343966","article-title":"Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment","volume":"28","author":"Raison","year":"2013","journal-title":"Mod. Trends Pharmacopsychiatr."},{"key":"10.1016\/j.ynstr.2020.100220_bib38","first-page":"1","article-title":"Biomarkers for treatment and diagnosis","volume":"26","author":"Rasmusson","year":"2015","journal-title":"PTSD Research Quarterly"},{"key":"10.1016\/j.ynstr.2020.100220_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0006-3223(99)00185-7","article-title":"Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD","volume":"47","author":"Rasmusson","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psyneuen.2018.11.027","article-title":"Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD","volume":"102","author":"Rasmusson","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ynstr.2020.100220_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11920-018-0908-9","article-title":"Neurotransmitter, peptide, and steroid hormone abnormalities in PTSD: biological endophenotypes relevant to treatment","volume":"20","author":"Rasmusson","year":"2018","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.ynstr.2020.100220_bib54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biopsych.2006.03.026","article-title":"Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder","volume":"60","author":"Rasmusson","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopsycho.2018.02.008","article-title":"Biological profiling of plasma neuropeptide Y in relation to posttraumatic stress symptoms in two combat cohorts","volume":"134","author":"Reijnen","year":"2018","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.ynstr.2020.100220_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psyneuen.2013.10.017","article-title":"Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder","volume":"40","author":"Sah","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ynstr.2020.100220_bib44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.biopsych.2009.04.037","article-title":"Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder","volume":"66","author":"Sah","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ynstr.2020.100220_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.psyneuen.2016.08.014","article-title":"Development of psychopathology in deployed armed forces in relation to plasma GABA levels","volume":"73","author":"Schur","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ynstr.2020.100220_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1682\/JRRD.2014.10.0267","article-title":"Potential neurobiological benefits of exercise in chronic pain and posttraumatic stress disorder: pilot study","volume":"53","author":"Scioli-Salter","year":"2016","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.ynstr.2020.100220_bib47","first-page":"77","article-title":"Estimating the risk of PTSD in recent trauma survivors: results of the International Consortium to Predict","volume":"18","author":"Shalev","year":"2019","journal-title":"PTSD (ICPP)"},{"key":"10.1016\/j.ynstr.2020.100220_bib48","doi-asserted-by":"crossref","first-page":"E1594","DOI":"10.1002\/humu.21299","article-title":"Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect","volume":"31","author":"Sommer","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ynstr.2020.100220_bib49","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1039\/C4MB00404C","article-title":"Systems biology approach to understanding post-traumatic stress disorder","volume":"11","author":"Thakur","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ynstr.2020.100220_bib50","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1523\/JNEUROSCI.4955-13.2016","article-title":"Neuropeptide Y impairs retrieval of extinguished fear and modulates excitability of neurons in the infralimbic prefrontal cortex","volume":"36","author":"Vollmer","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ynstr.2020.100220_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/da.1029","article-title":"Clinician-administered PTSD scale: a review of the first ten years of research","volume":"13","author":"Weathers","year":"2001","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ynstr.2020.100220_bib51","doi-asserted-by":"crossref","first-page":"20140048","DOI":"10.1098\/rsfs.2014.0048","article-title":"Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans","volume":"4","author":"Yehuda","year":"2014","journal-title":"Interface Focus"}],"container-title":["Neurobiology of Stress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352289520300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352289520300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:07:18Z","timestamp":1762448838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352289520300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":54,"alternative-id":["S2352289520300102"],"URL":"https:\/\/doi.org\/10.1016\/j.ynstr.2020.100220","relation":{},"ISSN":["2352-2895"],"issn-type":[{"value":"2352-2895","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Stress","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ynstr.2020.100220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100220"}}